Showing results (261-270 of 309) with videos related to
Sort By:
Pageof 31
The Journal of Biological Chemistry|May 15, 1993
Identification of a new receptor subtype for tumor necrosis factor-alphaD M Schwalb, H M Han, M Marino, et al.The Prostate|January 1, 1992
Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinomaJ L Mohler, L G Gomella, E D Crawford, et al.Cancer Research|November 15, 1987
Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinomaP Russo, G Liguori, W D Heston, et al.The Journal of Urology|October 11, 1992
Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancerJ C Presti, W R Fair, G Andriole, et al.Cancer Treatment Reports|May 1, 1983
Phase I trial of mitoxantrone by 24-hour continuous infusionK C Anderson, M B Garnick, M W Meshad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trialH W Herr, D M Schwalb, Z F Zhang, et al.Journal of Cellular Biochemistry. Supplement|January 1, 1992
Chemoprevention of prostate cancer: guidelines for possible intervention strategiesE D Crawford, W R Fair, G J Kelloff, et al.The Journal of Urology|August 1, 1996
Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancerS M Donat, H W Herr, D F Bajorin, et al.Cancer Treatment Reports|November 1, 1979
Phase I trial of bruceantinM B Garnick, R H Blum, G P Canellos, et al.The American Journal of Surgical Pathology|October 1, 1994
Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinomaO A Armas, A G Aprikian, J Melamed, et al.Pageof 31